ClinicalTrials.Veeva

Menu

The Role of Micrometastasis and Isolated Tumor Cells (ITCs) in Endometrial and Cervical Cancer. A Multicenter Study. (ITCMicroUtCa)

F

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Status

Enrolling

Conditions

Cervical Tumor
Endometrial Cancer
Sentinel Lymph Node
Lymph Node Disease
Lymph Node Metastases
Endometrium Tumor
Sentinel Lymph Node Biopsy
Micrometastasis
Cervical Neoplasm
Endometrial Neoplasms
Cervical Cancer

Treatments

Procedure: Sentinel lymph node (SLN) biosy +/- lymphadenectomy

Study type

Observational

Funder types

Other

Identifiers

NCT04403867
INT 135/19

Details and patient eligibility

About

The role of small-volume lymph node disease (ITC and micro metastases) among patients with endometrial or cervical cancer submitted to sentinel node (SLN) procedure is not clearly defined.

This study was designed to create a dataset of patients with lymph nodal disease. Data on type and volume of lymph nodal disease, therapeutic choices and oncological outcomes (DFS, OS, recurrence rate) will be collected and analyzed.

This will allow to define the groups of patients who may need or for whom it can be avoided any adjuvant treatment on the basis of lymph node status.

Enrollment

500 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Early stage endometrial cancer scheduled for SLN procedure
  • Early stage cervical cancer scheduled for SLN procedure
  • Pathological evaluation of SLNs with standard ultra-staging or one-step nucleic acid amplification (OSNA) for the detection of metastasis
  • Presence of lymph nodes metastasis (macrometastasis or low volume disease [micrometastasis and isolated tumor cells])

Exclusion criteria

  • Previous (<5 years) or concomitant malignancy other than non-melanoma skin cancer
  • Advanced/metastatic endometrial cancer
  • Locally advanced/metastatic cervical cancer

Trial design

500 participants in 2 patient groups

Endometrial cancer patients
Description:
Patients submitted to Sentinel Lymph Node (SLN) procedure. Patients with lymph nodal disease (macrometastasis, micrometastasis, isolated tumor cells).
Treatment:
Procedure: Sentinel lymph node (SLN) biosy +/- lymphadenectomy
Cervical cancer patients
Description:
Patients submitted to Sentinel Lymph Node (SLN) procedure. Patients with lymph nodal disease (macrometastasis, micrometastasis, isolated tumor cells).
Treatment:
Procedure: Sentinel lymph node (SLN) biosy +/- lymphadenectomy

Trial contacts and locations

1

Loading...

Central trial contact

Fabio Martinelli, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems